SCHEMBL24535938

SCHEMBL24535938

CN[C@H]1CN(C(C)C)C[C@H]1C

nearest known ligand 0.38

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
DRD4 P21917 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22489421 0.85
SCHEMBL24536027 0.85
SCHEMBL23750318 0.85
SCHEMBL23054421 0.85
SCHEMBL27391263 0.81 KDM1A (0.31) DRD4
SCHEMBL20069118 0.81 KDM1A (0.31)
SCHEMBL22489516 0.80 DRD4 (0.38) DRD4
SCHEMBL25876191 0.80 DRD4 (0.38) DRD4
SCHEMBL14925920 0.77 DRD4 (0.32) DRD4
SCHEMBL10129414 0.77 DRD4 (0.32) DRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022133034-A1 METHODS OF TREATING DISORDERS ASSOCIATED WITH CASTOR ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. (US) 2022-06-23 WO disclosed